Development of TCR-T therapy: Investigating hundreds of cancer specific antigens and tumor associated antigens and screening  thousands of  peptides to develop and validate solid tumor target genes and generate TCR-T clones.

Innovative Peptide Drug Conjugate (PDC) research: Utilizing verified functioning cancer peptides to conjugate small molecules or antibodies to discover specific functioning PDC

Improve peptide structure design to facilitate peptide cancer vaccine delivery system: Designing 2D and 3D peptide structures and testing in vitro and in vivo to reduce peptide disassociation rate and enhance peptide vaccine delivery

Seeking cooperation and collaboration worldwide for potential translational research projects